Partner Content Partner Content KOL Mapping and Validation You’ve done your KOL Mapping, and you have been in a therapy area for a while. You may have gotten used to working with the same KOLs and Experts over and over again.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
